Literature DB >> 9125162

Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF.

M Lopez-Ilasaca1, W Li, A Uren, J C Yu, A Kazlauskas, J S Gutkind, M A Heidaran.   

Abstract

The molecular mechanism by which cell surface receptors stimulate the serine/threonine kinase activity of c-Jun N-terminal kinases (JNKs) was investigated using a transient cotransfection experiments in COS-7 cells. Our data demonstrate that JNK activity is potently induced by platelet derived growth factor (PDGF) upon expression of beta PDGFR wild type (beta RWT). However, PDGF failed to mediate JNK activation in cells expressing beta PDGFR mutant lacking the binding site for phosphatidylinositol-3 (PI-3) kinase but not for phospholipase C gamma (PLC gamma) or Syp. Consistent with this result, a PI-3 kinase inhibitor, wortmannin inhibited activation of JNK by PDGF. Furthermore, overexpression of P110 the catalytic domain of PI-3 kinase was sufficient for activation of JNKs which could be efficiently inhibited by dominant negative forms of Ras, Rac but not of RhoA or Cdc42. Taken together all of these findings suggest that activation of JNK by PDGF involves receptor association with PI-3 kinase activity, which in turn acts on a ras- and rac-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125162     DOI: 10.1006/bbrc.1997.6289

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 2.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

Review 3.  Signals and Receptors.

Authors:  Carl-Henrik Heldin; Benson Lu; Ron Evans; J Silvio Gutkind
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-04-01       Impact factor: 10.005

4.  Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner.

Authors:  O Potapova; M Gorospe; R H Dougherty; N M Dean; W A Gaarde; N J Holbrook
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2.

Authors:  F S Santiago; H C Lowe; F L Day; C N Chesterman; L M Khachigian
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 6.  The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Kathy Q Cai; Michael F Ochs; Burton Eisenberg; Min Huang; Margaret von Mehren; Andrew K Godwin
Journal:  Cell Cycle       Date:  2008-10-07       Impact factor: 4.534

Review 7.  Chemokine signaling in cancer: one hump or two?

Authors:  Joshua B Rubin
Journal:  Semin Cancer Biol       Date:  2008-10-17       Impact factor: 15.707

Review 8.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 9.  Molecular research directions in the management of gastrointestinal stromal tumors.

Authors:  Chi Tarn; Andrew K Godwin
Journal:  Curr Treat Options Oncol       Date:  2005-11

10.  Src family tyrosine kinase regulates intracellular pH in cardiomyocytes.

Authors:  M Pucéat; S Roche; G Vassort
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.